Chondroitin 4‐sulphate exhibits inhibitory effect during Cu2+‐mediated LDL oxidation
© 1997 Federation of European Biochemical Societies.
Gespeichert in:
| Veröffentlicht in: | FEBS letters 1997-02, Vol.403 (2), p.154-158 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 158 |
|---|---|
| container_issue | 2 |
| container_start_page | 154 |
| container_title | FEBS letters |
| container_volume | 403 |
| creator | Albertini, Riccardo Ramos, Pilar Giessauf, Andreas Passi, Alberto De Luca, Giancarlo Esterbauer, Hermann |
| description | © 1997 Federation of European Biochemical Societies. |
| doi_str_mv | 10.1016/S0014-5793(97)00043-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78831377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78831377</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2034-60605254d0384410f0c81f52001fec0d95a78a61236b50f62ca8fe5a3032e1ca3</originalsourceid><addsrcrecordid>eNo9kN1KwzAYhoMoc04vYZAjUaT65adNcqh1c0LBAxU8C1mbukjXzqbF7cxL8Bq9ErtueJSPPO_3w4PQmMA1ARLdPAMQHoRCsQslLgGAs4AfoCGRggWMR_IQDf8jx-jE-48uRCRRAzRQwKkKxRC9xYuqzOrKNa7E_Pf7x7fFamEai-164eau8diVfVHVG2zz3KYNztrale84bulV17G0mesaMpzcJ7hau8w0ripP0VFuCm_P9u8IvU4nL_EsSJ4eHuPbJFhRYDyIIIKQhjwDJjknkEMqSR7S7tJuFWQqNEKaiFAWzUPII5oamdvQMGDUktSwETrfzV3V1WdrfaOXzqe2KExpq9ZrISUjTIguON4H23l3sl7Vbmnqjd6r6Phsx79cYTf_mIDe6ta9br11qZXQvW7N9XRyR3uyBUr035z9AUcVdjk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78831377</pqid></control><display><type>article</type><title>Chondroitin 4‐sulphate exhibits inhibitory effect during Cu2+‐mediated LDL oxidation</title><source>Wiley-Blackwell Open Access Backfiles</source><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>Wiley Blackwell Single Titles</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Albertini, Riccardo ; Ramos, Pilar ; Giessauf, Andreas ; Passi, Alberto ; De Luca, Giancarlo ; Esterbauer, Hermann</creator><creatorcontrib>Albertini, Riccardo ; Ramos, Pilar ; Giessauf, Andreas ; Passi, Alberto ; De Luca, Giancarlo ; Esterbauer, Hermann</creatorcontrib><description>© 1997 Federation of European Biochemical Societies.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1016/S0014-5793(97)00043-4</identifier><identifier>PMID: 9042957</identifier><language>eng</language><publisher>England</publisher><subject>2,2′-azobis(2-amidinopropane hydrochloride) ; AAPH ; Adult ; C4S ; C6S ; chondroitin 4-sulphate ; chondroitin 6-sulphate ; Chondroitin sulfate ; Chondroitin Sulfates - pharmacology ; chondroitin sulphate ; conjugated diene ; Copper - pharmacology ; Copper oxidation ; Female ; GAG ; GalNAc-4S ; GalNAc-6S ; Glycosaminoglycan ; Humans ; Kinetics ; LDL ; Lipoproteins, LDL - metabolism ; Low density lipoprotein ; Male ; N-acetylgalactosamine 4-sulphate ; N-acetylgalactosamine 6-sulphate ; Oxidation-Reduction ; PBS ; phosphate-buffered saline ; Trp ; tryptophan ; Tryptophan - metabolism ; unsaturated uronic acid ; ΔUA</subject><ispartof>FEBS letters, 1997-02, Vol.403 (2), p.154-158</ispartof><rights>FEBS Letters 403 (1997) 1873-3468 © 2015 Federation of European Biochemical Societies</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1016%2FS0014-5793%2897%2900043-4$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1016%2FS0014-5793%2897%2900043-4$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9042957$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Albertini, Riccardo</creatorcontrib><creatorcontrib>Ramos, Pilar</creatorcontrib><creatorcontrib>Giessauf, Andreas</creatorcontrib><creatorcontrib>Passi, Alberto</creatorcontrib><creatorcontrib>De Luca, Giancarlo</creatorcontrib><creatorcontrib>Esterbauer, Hermann</creatorcontrib><title>Chondroitin 4‐sulphate exhibits inhibitory effect during Cu2+‐mediated LDL oxidation</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>© 1997 Federation of European Biochemical Societies.</description><subject>2,2′-azobis(2-amidinopropane hydrochloride)</subject><subject>AAPH</subject><subject>Adult</subject><subject>C4S</subject><subject>C6S</subject><subject>chondroitin 4-sulphate</subject><subject>chondroitin 6-sulphate</subject><subject>Chondroitin sulfate</subject><subject>Chondroitin Sulfates - pharmacology</subject><subject>chondroitin sulphate</subject><subject>conjugated diene</subject><subject>Copper - pharmacology</subject><subject>Copper oxidation</subject><subject>Female</subject><subject>GAG</subject><subject>GalNAc-4S</subject><subject>GalNAc-6S</subject><subject>Glycosaminoglycan</subject><subject>Humans</subject><subject>Kinetics</subject><subject>LDL</subject><subject>Lipoproteins, LDL - metabolism</subject><subject>Low density lipoprotein</subject><subject>Male</subject><subject>N-acetylgalactosamine 4-sulphate</subject><subject>N-acetylgalactosamine 6-sulphate</subject><subject>Oxidation-Reduction</subject><subject>PBS</subject><subject>phosphate-buffered saline</subject><subject>Trp</subject><subject>tryptophan</subject><subject>Tryptophan - metabolism</subject><subject>unsaturated uronic acid</subject><subject>ΔUA</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kN1KwzAYhoMoc04vYZAjUaT65adNcqh1c0LBAxU8C1mbukjXzqbF7cxL8Bq9ErtueJSPPO_3w4PQmMA1ARLdPAMQHoRCsQslLgGAs4AfoCGRggWMR_IQDf8jx-jE-48uRCRRAzRQwKkKxRC9xYuqzOrKNa7E_Pf7x7fFamEai-164eau8diVfVHVG2zz3KYNztrale84bulV17G0mesaMpzcJ7hau8w0ripP0VFuCm_P9u8IvU4nL_EsSJ4eHuPbJFhRYDyIIIKQhjwDJjknkEMqSR7S7tJuFWQqNEKaiFAWzUPII5oamdvQMGDUktSwETrfzV3V1WdrfaOXzqe2KExpq9ZrISUjTIguON4H23l3sl7Vbmnqjd6r6Phsx79cYTf_mIDe6ta9br11qZXQvW7N9XRyR3uyBUr035z9AUcVdjk</recordid><startdate>19970217</startdate><enddate>19970217</enddate><creator>Albertini, Riccardo</creator><creator>Ramos, Pilar</creator><creator>Giessauf, Andreas</creator><creator>Passi, Alberto</creator><creator>De Luca, Giancarlo</creator><creator>Esterbauer, Hermann</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19970217</creationdate><title>Chondroitin 4‐sulphate exhibits inhibitory effect during Cu2+‐mediated LDL oxidation</title><author>Albertini, Riccardo ; Ramos, Pilar ; Giessauf, Andreas ; Passi, Alberto ; De Luca, Giancarlo ; Esterbauer, Hermann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2034-60605254d0384410f0c81f52001fec0d95a78a61236b50f62ca8fe5a3032e1ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>2,2′-azobis(2-amidinopropane hydrochloride)</topic><topic>AAPH</topic><topic>Adult</topic><topic>C4S</topic><topic>C6S</topic><topic>chondroitin 4-sulphate</topic><topic>chondroitin 6-sulphate</topic><topic>Chondroitin sulfate</topic><topic>Chondroitin Sulfates - pharmacology</topic><topic>chondroitin sulphate</topic><topic>conjugated diene</topic><topic>Copper - pharmacology</topic><topic>Copper oxidation</topic><topic>Female</topic><topic>GAG</topic><topic>GalNAc-4S</topic><topic>GalNAc-6S</topic><topic>Glycosaminoglycan</topic><topic>Humans</topic><topic>Kinetics</topic><topic>LDL</topic><topic>Lipoproteins, LDL - metabolism</topic><topic>Low density lipoprotein</topic><topic>Male</topic><topic>N-acetylgalactosamine 4-sulphate</topic><topic>N-acetylgalactosamine 6-sulphate</topic><topic>Oxidation-Reduction</topic><topic>PBS</topic><topic>phosphate-buffered saline</topic><topic>Trp</topic><topic>tryptophan</topic><topic>Tryptophan - metabolism</topic><topic>unsaturated uronic acid</topic><topic>ΔUA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Albertini, Riccardo</creatorcontrib><creatorcontrib>Ramos, Pilar</creatorcontrib><creatorcontrib>Giessauf, Andreas</creatorcontrib><creatorcontrib>Passi, Alberto</creatorcontrib><creatorcontrib>De Luca, Giancarlo</creatorcontrib><creatorcontrib>Esterbauer, Hermann</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Albertini, Riccardo</au><au>Ramos, Pilar</au><au>Giessauf, Andreas</au><au>Passi, Alberto</au><au>De Luca, Giancarlo</au><au>Esterbauer, Hermann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chondroitin 4‐sulphate exhibits inhibitory effect during Cu2+‐mediated LDL oxidation</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>1997-02-17</date><risdate>1997</risdate><volume>403</volume><issue>2</issue><spage>154</spage><epage>158</epage><pages>154-158</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>© 1997 Federation of European Biochemical Societies.</abstract><cop>England</cop><pmid>9042957</pmid><doi>10.1016/S0014-5793(97)00043-4</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0014-5793 |
| ispartof | FEBS letters, 1997-02, Vol.403 (2), p.154-158 |
| issn | 0014-5793 1873-3468 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78831377 |
| source | Wiley-Blackwell Open Access Backfiles; MEDLINE; Access via ScienceDirect (Elsevier); Wiley Blackwell Single Titles; Alma/SFX Local Collection; EZB Electronic Journals Library |
| subjects | 2,2′-azobis(2-amidinopropane hydrochloride) AAPH Adult C4S C6S chondroitin 4-sulphate chondroitin 6-sulphate Chondroitin sulfate Chondroitin Sulfates - pharmacology chondroitin sulphate conjugated diene Copper - pharmacology Copper oxidation Female GAG GalNAc-4S GalNAc-6S Glycosaminoglycan Humans Kinetics LDL Lipoproteins, LDL - metabolism Low density lipoprotein Male N-acetylgalactosamine 4-sulphate N-acetylgalactosamine 6-sulphate Oxidation-Reduction PBS phosphate-buffered saline Trp tryptophan Tryptophan - metabolism unsaturated uronic acid ΔUA |
| title | Chondroitin 4‐sulphate exhibits inhibitory effect during Cu2+‐mediated LDL oxidation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A01%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chondroitin%204%E2%80%90sulphate%20exhibits%20inhibitory%20effect%20during%20Cu2+%E2%80%90mediated%20LDL%20oxidation&rft.jtitle=FEBS%20letters&rft.au=Albertini,%20Riccardo&rft.date=1997-02-17&rft.volume=403&rft.issue=2&rft.spage=154&rft.epage=158&rft.pages=154-158&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1016/S0014-5793(97)00043-4&rft_dat=%3Cproquest_pubme%3E78831377%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78831377&rft_id=info:pmid/9042957&rfr_iscdi=true |